account_num,net_change,tag,tag_depth,cik
1264,-12222000.0,OperatingIncomeLoss,1,886163_LIGAND PHARMACEUTICALS INC
2399,12803000.0,IncomeTaxExpenseBenefit,1,886163_LIGAND PHARMACEUTICALS INC
2257,-58707000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,886163_LIGAND PHARMACEUTICALS INC
2149,-59231000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,886163_LIGAND PHARMACEUTICALS INC
1854,524000.0,InterestAndDebtExpense,2,886163_LIGAND PHARMACEUTICALS INC
1709,524000.0,InterestExpense,1,886163_LIGAND PHARMACEUTICALS INC
2130,-46485000.0,NonoperatingIncomeExpense,1,886163_LIGAND PHARMACEUTICALS INC
1205,-47279000.0,InvestmentIncomeNonoperating,2,886163_LIGAND PHARMACEUTICALS INC
1665,-3755000.0,InvestmentIncomeNet,2,886163_LIGAND PHARMACEUTICALS INC
1340,-3755000.0,InvestmentIncomeInterest,2,886163_LIGAND PHARMACEUTICALS INC
1112,80265000.0,OperatingExpenses,1,886163_LIGAND PHARMACEUTICALS INC
601,22142000.0,SellingGeneralAndAdministrativeExpense,3,886163_LIGAND PHARMACEUTICALS INC
597,22142000.0,GeneralAndAdministrativeExpense,2,886163_LIGAND PHARMACEUTICALS INC
232,-22464000.0,GrossProfit,1,886163_LIGAND PHARMACEUTICALS INC
3917,-758105000.0,LiabilitiesAndStockholdersEquity,2,886163_LIGAND PHARMACEUTICALS INC
3260,-664892000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,886163_LIGAND PHARMACEUTICALS INC
3316,-664892000.0,StockholdersEquity,1,886163_LIGAND PHARMACEUTICALS INC
3834,-495101000.0,RetainedEarningsAccumulatedDeficit,1,886163_LIGAND PHARMACEUTICALS INC
3750,-170741000.0,AdditionalPaidInCapital,1,886163_LIGAND PHARMACEUTICALS INC
3661,-17000.0,CommonStockValue,3,886163_LIGAND PHARMACEUTICALS INC
3465,-93213000.0,Liabilities,1,886163_LIGAND PHARMACEUTICALS INC
3645,-60320000.0,LiabilitiesNoncurrent,2,886163_LIGAND PHARMACEUTICALS INC
3796,-60320000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,886163_LIGAND PHARMACEUTICALS INC
3379,-10991000.0,OperatingLeaseLiabilityNoncurrent,3,886163_LIGAND PHARMACEUTICALS INC
3154,-29388000.0,LiabilitiesCurrent,2,886163_LIGAND PHARMACEUTICALS INC
1820,-71510000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,886163_LIGAND PHARMACEUTICALS INC
1077,-71510000.0,ProfitLoss,2,886163_LIGAND PHARMACEUTICALS INC
1912,-44239000.0,NetIncomeLoss,1,886163_LIGAND PHARMACEUTICALS INC
2590,-44239000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,886163_LIGAND PHARMACEUTICALS INC
300,5386000.0,CostDirectMaterial,2,886163_LIGAND PHARMACEUTICALS INC
371,17078000.0,CostOfGoodsAndServicesSoldAmortization,2,886163_LIGAND PHARMACEUTICALS INC
427,17078000.0,CostDepreciationAmortizationAndDepletion,4,886163_LIGAND PHARMACEUTICALS INC
433,17078000.0,CostOfGoodsAndServicesSoldDepreciationAndAmortization,3,886163_LIGAND PHARMACEUTICALS INC
1572,3762000.0,FinanceLeaseRightOfUseAsset,3,886163_LIGAND PHARMACEUTICALS INC
1230,-43524000.0,GainLossOnInvestments,1,886163_LIGAND PHARMACEUTICALS INC
1781,-43524000.0,NonoperatingGainsLosses,1,886163_LIGAND PHARMACEUTICALS INC
2841,-11387000.0,TaxesPayableCurrent,2,886163_LIGAND PHARMACEUTICALS INC
757,2770000.0,OtherAssetsCurrent,2,886163_LIGAND PHARMACEUTICALS INC
2603,-70345000.0,NoninterestIncome,1,886163_LIGAND PHARMACEUTICALS INC
3017,-448000.0,OtherLiabilitiesCurrent,2,886163_LIGAND PHARMACEUTICALS INC
110,-70345000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,886163_LIGAND PHARMACEUTICALS INC
581,58123000.0,OperatingCostsAndExpenses,2,886163_LIGAND PHARMACEUTICALS INC
491,13517000.0,ResearchAndDevelopmentExpense,2,886163_LIGAND PHARMACEUTICALS INC
144,22464000.0,CostOfRevenue,1,886163_LIGAND PHARMACEUTICALS INC
171,22464000.0,CostOfGoodsAndServicesSold,2,886163_LIGAND PHARMACEUTICALS INC
162,5386000.0,CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization,6,886163_LIGAND PHARMACEUTICALS INC
3809,-967000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,886163_LIGAND PHARMACEUTICALS INC
3494,-21664000.0,OtherLiabilitiesNoncurrent,2,886163_LIGAND PHARMACEUTICALS INC
3383,-27665000.0,DeferredIncomeTaxLiabilitiesNet,2,886163_LIGAND PHARMACEUTICALS INC
2552,-7291000.0,AccruedLiabilitiesCurrent,2,886163_LIGAND PHARMACEUTICALS INC
1901,8530000.0,DeferredIncomeTaxAssetsNet,2,886163_LIGAND PHARMACEUTICALS INC
281,190596000.0,ShortTermInvestments,1,886163_LIGAND PHARMACEUTICALS INC
2903,-44239000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,886163_LIGAND PHARMACEUTICALS INC
2004,-270000.0,OtherNonoperatingIncomeExpense,1,886163_LIGAND PHARMACEUTICALS INC
2347,-16873000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,886163_LIGAND PHARMACEUTICALS INC
2089,758105000.0,Assets,1,886163_LIGAND PHARMACEUTICALS INC
2091,470611000.0,AssetsNoncurrent,2,886163_LIGAND PHARMACEUTICALS INC
2041,4495000.0,OtherAssetsNoncurrent,2,886163_LIGAND PHARMACEUTICALS INC
1827,431050000.0,IntangibleAssetsNetIncludingGoodwill,2,886163_LIGAND PHARMACEUTICALS INC
1732,325377000.0,IntangibleAssetsNetExcludingGoodwill,2,886163_LIGAND PHARMACEUTICALS INC
1711,105673000.0,Goodwill,1,886163_LIGAND PHARMACEUTICALS INC
1368,11382000.0,PropertyPlantAndEquipmentNet,4,886163_LIGAND PHARMACEUTICALS INC
1634,11392000.0,OperatingLeaseRightOfUseAsset,2,886163_LIGAND PHARMACEUTICALS INC
868,276711000.0,AssetsCurrent,2,886163_LIGAND PHARMACEUTICALS INC
260,26906000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,886163_LIGAND PHARMACEUTICALS INC
455,26906000.0,InventoryNet,2,886163_LIGAND PHARMACEUTICALS INC
320,27994000.0,ReceivablesNetCurrent,3,886163_LIGAND PHARMACEUTICALS INC
207,27994000.0,AccountsNotesAndLoansReceivableNetCurrent,4,886163_LIGAND PHARMACEUTICALS INC
2398,-9582000.0,AccountsPayableCurrent,2,886163_LIGAND PHARMACEUTICALS INC
229,27994000.0,AccountsReceivableNetCurrent,3,886163_LIGAND PHARMACEUTICALS INC
645,28445000.0,CashAndCashEquivalentsAtCarryingValue,3,886163_LIGAND PHARMACEUTICALS INC
577,219041000.0,CashCashEquivalentsAndShortTermInvestments,4,886163_LIGAND PHARMACEUTICALS INC
1563,-3755000.0,InvestmentIncomeInterestAndDividend,3,886163_LIGAND PHARMACEUTICALS INC
